With the price of bringing a drug to market estimated at $2.5 billion,1 avoidable cost increases caused by delays is a failing few companies are willing to swallow.
Move compound supply issues off the critical path. Insist on a close working relationship between your medicinal, process, and manufacturing chemists. Register for our webinar to learn how to ensure seamless supply and clinical success. Plan early, deliver fast.
Andy Baxter, PhD
Director and Discovery and Development Consultant
Paul Quigley, PhD
Head Of Drug Substance and Isotope Labelling
Chris Hurley, PhD
Director of Chemistry
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.